Akiram Therapeutics is a company headquartered in Sweden.
Akiram Therapeutics develops targeted radioimmunotherapy treatments using radioactive molecules to precisely diagnose and treat solid tumors, focusing on metastatic cancers with a therapeutic approach that minimizes damage to healthy tissue.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.